Cargando…

A cross-sectional study of cognitive performance in bipolar disorder across the lifespan: the cog-BD project

BACKGROUND: Neuroprogressive models of the trajectory of cognitive dysfunction in patients with bipolar disorder (BD) have been proposed. However, few studies have explored the relationships among clinical characteristics of BD, cognitive dysfunction, and aging. METHODS: We conducted a cross-section...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jones, Brett D. M., Fernandes, Brisa S., Husain, M. Ishrat, Ortiz, Abigail, Rajji, Tarek K., Blumberger, Daniel M., Butters, Meryl A., Gildengers, Ariel G., Shablinski, Tatiana, Voineskos, Aristotle, Mulsant, Benoit H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520592/ https://www.ncbi.nlm.nih.gov/pubmed/36464659 http://dx.doi.org/10.1017/S0033291722003622

Ejemplares similares

Protocol for a systematic review and meta-analysis of coordinate-based network mapping of brain structure in bipolar disorder across the lifespan
por: Jones, Brett D. M., et al.
Publicado: (2023)

Evidence for Structural and Functional Alterations of Frontal-Executive and Corticolimbic Circuits in Late-Life Depression and Relationship to Mild Cognitive Impairment and Dementia: A Systematic Review
por: Rashidi-Ranjbar, Neda, et al.
Publicado: (2020)

Physical activity and brain plasticity in late adulthood
por: Erickson, Kirk I., et al.
Publicado: (2013)

Bipolar I and bipolar II subtypes in older age: Results from the Global Aging and Geriatric Experiments in Bipolar Disorder (GAGE‐BD) project
por: Beunders, Alexandra J. M., et al.
Publicado: (2022)

Predictors of adherence to electronic self-monitoring in patients with bipolar disorder: a contactless study using Growth Mixture Models
por: Ortiz, Abigail, et al.
Publicado: (2023)

COVID-19: Implications for bipolar disorder clinical care and research
por: Xue, Siqi, et al.
Publicado: (2020)

Resting and TMS-EEG markers of treatment response in major depressive disorder: A systematic review
por: Strafella, Rebecca, et al.
Publicado: (2022)

Psychosocial Risk Factors for Cognitive Decline in Late-Life Depression: Findings from the MTLD-III Study
por: Rej, Soham, et al.
Publicado: (2015)

A Review of Impaired Neuroplasticity in Schizophrenia Investigated with Non-invasive Brain Stimulation
por: Bhandari, Apoorva, et al.
Publicado: (2016)

Magnetic Seizure Therapy for Suicidality in Treatment-Resistant Depression
por: Weissman, Cory R., et al.
Publicado: (2020)

Myelin-Associated Glycoprotein Gene and Brain Morphometry in Schizophrenia
por: Felsky, Daniel, et al.
Publicado: (2012)

Brain-cognition relationships in late-life depression: a systematic review of structural magnetic resonance imaging studies
por: Marawi, Tulip, et al.
Publicado: (2023)

Impaired illness awareness in schizophrenia and posterior corpus callosal white matter tract integrity
por: Gerretsen, Philip, et al.
Publicado: (2019)

Predictors of adherence to electronic self-monitoring in patients with bipolar disorder: a contactless study using Growth Mixture Models
por: Ortiz, A., et al.
Publicado: (2023)

Astrocytes in the Neuropathology of Bipolar Disorder: Review of Current Evidence
por: Dai, Nasia, et al.
Publicado: (2022)

Placebo response in treatment resistant depression: a systematic review and meta-analysis of multiple treatment modalities
por: Jones, Brett D M, et al.
Publicado: (2021)

Brief App-Based Cognitive Behavioral Therapy for Anxiety Symptoms in Psychiatric Inpatients: Feasibility Randomized Controlled Trial
por: Sharma, Gaurav, et al.
Publicado: (2022)

Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial
por: Husain, Muhammad Ishrat, et al.
Publicado: (2023)

Neurexin-1 and Frontal Lobe White Matter: An Overlapping Intermediate Phenotype for Schizophrenia and Autism Spectrum Disorders
por: Voineskos, Aristotle N., et al.
Publicado: (2011)

Magnitude of the Placebo Response Across Treatment Modalities Used for Treatment-Resistant Depression in Adults: A Systematic Review and Meta-analysis
por: Jones, Brett D. M., et al.
Publicado: (2021)

The COVID-19 Global Pandemic: Implications for People With Schizophrenia and Related Disorders
por: Kozloff, Nicole, et al.
Publicado: (2020)

Superior memory performance in healthy individuals with subclinical psychotic symptoms but without genetic load for schizophrenia
por: Gagnon, G., et al.
Publicado: (2018)

The Relationship Between Cortical Inhibition and Electroconvulsive Therapy in the Treatment of Major Depressive Disorder
por: Voineskos, Daphne, et al.
Publicado: (2016)

Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action?
por: Husain, Muhammad Ishrat, et al.
Publicado: (2023)

Association of Molecular Senescence Markers in Late-Life Depression With Clinical Characteristics and Treatment Outcome
por: Diniz, Breno S., et al.
Publicado: (2022)

Targeting Metabolic Dysfunction for the Treatment of Mood Disorders: Review of the Evidence
por: Jones, Brett D. M., et al.
Publicado: (2021)

Magnetic seizure therapy reduces suicidal ideation and produces neuroplasticity in treatment-resistant depression
por: Sun, Yinming, et al.
Publicado: (2018)

Assessing the Role of Past Depression in Patients with Mild Cognitive Impairment, with and without Biomarkers for Alzheimer’s Disease
por: Golas, Angela C., et al.
Publicado: (2023)

Isolating sensory artifacts in the suprathreshold TMS-EEG signal over DLPFC
por: Poorganji, Mohsen, et al.
Publicado: (2023)

Mild cognitive impairment and major depressive disorder are associated with molecular senescence abnormalities in older adults
por: Diniz, Breno S., et al.
Publicado: (2021)

Comparing the distribution of neuropsychiatric symptoms among individuals with depression and mild cognitive impairment
por: Keng, A., et al.
Publicado: (2023)

Higher illness burden is associated with reduced heart rate variability in bipolar disorder
por: Ortiz, A., et al.
Publicado: (2021)

A systematic review on the effectiveness of dialectical behavior therapy for improving mood symptoms in bipolar disorders
por: Jones, Brett D. M., et al.
Publicado: (2023)

Neural Correlates of the DEEPP (Anti-suicidal Response to Ketamine in Treatment-Resistant Bipolar Depression) Study: Protocol for a Pilot, Open-Label Clinical Trial
por: Knyahnytska, Yuliya, et al.
Publicado: (2023)

Enhancing Cognition in Older Persons with Depression or Anxiety with a Combination of Mindfulness-Based Stress Reduction (MBSR) and Transcranial Direct Current Stimulation (tDCS): Results of a Pilot Randomized Clinical Trial
por: Brooks, Heather, et al.
Publicado: (2021)

The SORL1 Gene and Convergent Neural Risk for Alzheimer's Disease Across the Human Lifespan
por: Felsky, Daniel, et al.
Publicado: (2013)

Weight Gain During Treatment of Bipolar Disorder (BD)—Facts and Therapeutic Options
por: Mangge, Harald, et al.
Publicado: (2019)

Examining Patterns of Polypharmacy in Bipolar Disorder: Findings from the REAP-BD, Korea
por: Kim, Kiwon, et al.
Publicado: (2019)

Cortical inhibition, facilitation and plasticity in late-life depression: effects of venlafaxine pharmacotherapy
por: Lissemore, Jennifer I., et al.
Publicado: (2021)

Clinical management and burden of bipolar disorder: a multinational longitudinal study (WAVE-bd Study)
por: Vieta, Eduard, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_20uq17j44d34vt3peo7fo3pgtq